The new plant will be dedicated to the manufacturing of a broad range of waterproofing and construction chemicals solutions, as well as 3D printing solutions to support the Group’s pioneer positioning in this new market segment
NATCO and Arrow shall launch the product on agreed-upon launch dates in the future.
The company reported total income of Rs.1475.59 crores during the 12 months period ended March 31, 2021
Her election becomes effective on June 1, 2021
PPG expects that all conditions to the completion of the tender offer will be fulfilled at the tender offer expiration date of June 4, 2021.
It is estimated that the annual power generation of the project is 127,000 to 147,000 kWh
The company launched and expanded sales of acrylic rubber and non-phthalate allyl resins
Q4 FY21 revenues reached Rs. 1,469 crore, up by 39% Y-o-Y whereas Profit After Tax at Rs. 290 crore, rose 68% on a Y-o-Y basis
Company is investing 117 million euros to strengthen its global leadership in the manufacture of LAB, which will enable it to increase production to meet the growing demand generated by the COVID-19 pandemic
The cause has been identified and the restoration of the systems has begun
The Bakersfield biorefinery will process up to 15,000 barrels per day of renewable feedstock
Evaluation was based on specific criteria that analyzed the company’s overall completeness of vision and ability to execute
First batch produced at Panacea Biotec’s facilities at Baddi will be shipped to the Gamaleya Center for quality control and full scale production of the vaccine is due to start this summer
.jpg)
Carroll as Vice President, automotive OEM, Americas and Mobility
Santanu Chatterjee’s sudden and unexpected death will be an irreparable loss to the company
We focused on developing the product last year but now our focus is on ramping up our manufacturing capacity
NATCO Pharmaceuticals, Hyderabad; Alembic Pharmaceuticals, Vadodara; Gufic Biosciences Ltd., Gujarat; Emcure Pharmaceuticals, Pune; and Lyka, Gujarat are new manufacturers
The company reported total income of Rs.455.28 crores during the 12 months period ended March 31, 2021
The product patent has been already filed under fast track approval
Allecra Therapeutics would now either directly or through out license file for NDA of this molecule.
Subscribe to our newsletter & stay updated.
